Diabetes Care
29:356-362,
2006
DOI: 10.2337/diacare.29.02.06.dc05-1963
© 2006 by the American Diabetes Association
Pathophysiology/Complications Original Article |
Impact of Differences in Fasting Glucose and Glucose Tolerance on the Hyperbolic Relationship Between Insulin Sensitivity and Insulin Responses
Kristina M. Utzschneider, MD1,
Ronald L. Prigeon, MD2,
Darcy B. Carr, MD3,
Rebecca L. Hull, PHD1,
Jenny Tong, MD1,
Jane B. Shofer, MS4,
Barbara M. Retzlaff, RN1,
Robert H. Knopp, MD1 and
Steven E. Kahn, MB, CHB1
1 Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, VA Puget Sound Health Care System and Harborview Medical Center, University of Washington, Seattle, Washington
2 Geriatric Research, Education and Clinical Center, Baltimore VA Medical Center and Division of Gerontology, University of Maryland School of Medicine, Baltimore, Maryland
3 Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Washington, Seattle, Washington
4 Rehabilitation, Research and Development Center, VA Puget Sound Health Care System, Seattle, Washington
Address correspondence and reprint requests to Kristina M. Utzschneider, MD, VA Puget Sound Health Care System (151), 1660 S. Columbian Way, Seattle, WA 98108. E-mail: kutzschn{at}u.washington.edu
OBJECTIVETo determine whether the hyperbolic relationship between insulin sensitivity and the acute insulin response to glucose (AIRg) exists in subjects with impaired fasting glucose (IFG) or decreased glucose tolerance.
RESEARCH DESIGN AND METHODSWe studied 219 healthy subjects (88 male and 131 female subjects, aged 2675 years) with fasting plasma glucose (FPG) <6.11 mmol/l. Subjects underwent an intravenous glucose tolerance test to determine the insulin sensitivity index (Si), AIRg, and the glucose disappearance constant (Kg), the latter a measure of intravenous glucose tolerance.
RESULTSSi and AIRg were inversely related for the entire cohort, and this relationship was not significantly different from hyperbolic. The inverse relationship between Si and AIRg was not significantly different when compared between groups based on fasting glucose (normal fasting glucose [NFG], FPG <5.56 mmol/l vs. IFG, FPG 5.566.11 mmol/l) or by the Kg quartile. However, the curve relating Si and AIRg was left shifted in the IFG compared with NFG group (P < 0.001) and was progressively more left shifted with decreasing Kg (P < 0.001), consistent with decreasing ß-cell function. These changes were not observed for the curves relating Si and fasting insulin, suggesting that in the fasting state ß-cell function is maintained even in patients with mild IFG. Finally, the disposition index (DI) (Si x AIRg) was calculated as a measure of ß-cell function. The DI progressively decreased with increasing FPG, even in the group of subjects classified as NFG.
CONCLUSIONSThe inverse relationship between insulin sensitivity and AIRg is consistent with a hyperbola not only in subjects with normal glucose tolerance but also with mild IFG or decreased Kg. Based on a hyperbolic relationship, a decrease in ß-cell function can be detected as FPG increases, even in patients who are normal glucose tolerant.
Abbreviations: AIRg, acute insulin response to glucose DI, disposition index FPG, fasting plasma glucose IFG, impaired fasting glucose NFG, normal fasting glucose

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. I. Tarasov, T. J. Nicolson, J.-P. Riveline, T. K. Taneja, S. A. Baldwin, J. M. Baldwin, G. Charpentier, J.-F. Gautier, P. Froguel, M. Vaxillaire, et al.
A Rare Mutation in ABCC8/SUR1 Leading to Altered ATP-Sensitive K+ Channel Activity and {beta}-Cell Glucose Sensing Is Associated With Type 2 Diabetes in Adults
Diabetes,
June 1, 2008;
57(6):
1595 - 1604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Utzschneider, J. Tong, B. Montgomery, J. Udayasankar, F. Gerchman, S. M. Marcovina, C. E. Watson, M. A. Ligueros-Saylan, J. E. Foley, J. J. Holst, et al.
The Dipeptidyl Peptidase-4 Inhibitor Vildagliptin Improves -Cell Function and Insulin Sensitivity in Subjects With Impaired Fasting Glucose
Diabetes Care,
January 1, 2008;
31(1):
108 - 113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Rasouli, H. J. Spencer, A. A. Rashidi, and S. C. Elbein
Impact of Family History of Diabetes and Ethnicity on -Cell Function in Obese, Glucose-Tolerant Individuals
J. Clin. Endocrinol. Metab.,
December 1, 2007;
92(12):
4656 - 4663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Crutchlow, B. Robinson, B. Pappachen, N. Wimmer, A. J. Cucchiara, D. Cohen, and R. Townsend
Validation of Steady-State Insulin Sensitivity Indices in Chronic Kidney Disease
Diabetes Care,
July 1, 2007;
30(7):
1813 - 1818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bock, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, V. Chandramouli, B. R. Landau, and R. A. Rizza
Contribution of Hepatic and Extrahepatic Insulin Resistance to the Pathogenesis of Impaired Fasting Glucose: Role of Increased Rates of Gluconeogenesis
Diabetes,
June 1, 2007;
56(6):
1703 - 1711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sakaue, S. Ishimaru, D. Ikeda, Y. Ohtsuka, T. Honda, J.-i. Suzuki, Y. Kawakami, J. Ishii, and M. Nishimura
Estimation of beta-cell function from the data of the oral glucose tolerance test
Am J Physiol Endocrinol Metab,
June 1, 2007;
292(6):
E1575 - E1580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bock, C. Dalla Man, M. Campioni, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, and R. Rizza
Effects of Nonglucose Nutrients on Insulin Secretion and Action in People With Pre-Diabetes
Diabetes,
April 1, 2007;
56(4):
1113 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cnop, J. Vidal, R. L. Hull, K. M. Utzschneider, D. B. Carr, T. Schraw, P. E. Scherer, E. J. Boyko, W. Y. Fujimoto, and S. E. Kahn
Progressive Loss of {beta}-Cell Function Leads to Worsening Glucose Tolerance in First-Degree Relatives of Subjects With Type 2 Diabetes
Diabetes Care,
March 1, 2007;
30(3):
677 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Rasouli, P. A Kern, E. A. Reece, and S. C. Elbein
Effects of pioglitazone and metformin on beta-cell function in nondiabetic subjects at high risk for type 2 diabetes
Am J Physiol Endocrinol Metab,
January 1, 2007;
292(1):
E359 - E365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bock, C. Dalla Man, M. Campioni, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, and R. Rizza
Pathogenesis of Pre-Diabetes: Mechanisms of Fasting and Postprandial Hyperglycemia in People With Impaired Fasting Glucose and/or Impaired Glucose Tolerance
Diabetes,
December 1, 2006;
55(12):
3536 - 3549.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Diabetes Association.
|
|
| |
|